Natera (NTRA) P/E (2015 - 2026)
Natera (NTRA) P/E from Jul 2, 2015 to Jul 20, 2026. The TTM Natera (NTRA) P/E is -160.88. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Natera (NTRA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -160.88 | +7.36% |
| 2025 | -149.86 | +43.56% |
| 2024 | -104.38 | +629.43% |
| 2023 | -14.31 | +101.76% |
| 2022 | -7.09 | -61.12% |
| 2021 | -18.24 | -49.26% |
| 2020 | -35.96 | +89.83% |
| 2019 | -18.94 | +199.70% |
| 2018 | -6.32 | +76.70% |
| 2017 | -3.58 | -54.93% |
| 2016 | -7.94 | +157.40% |
| 2015 | -3.08 | N/A |
Comparison Natera (NTRA) P/E with competitors
Natera (NTRA) P/E is -160.88.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -100.65% |
| MBAI | CheckCap Ltd | 1.71 | -101.06% |
| FONR | Fonar Corp | 15.48 | -109.62% |
| QGEN | Qiagen NV | 20.03 | -112.45% |
| DGX | Quest Diagnostics Inc | 22.47 | -113.97% |
| LH | Laboratory Corp Of America Holdings | 23.87 | -114.84% |
| IQV | IQVIA Holdings Inc | 25.28 | -115.71% |
| A | Agilent Technologies Inc | 26.96 | -116.76% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | -119.60% |
| MTD | Mettler-Toledo International Inc | 32.45 | -120.17% |
| MEDP | Medpace Holdings Inc | 32.55 | -120.23% |
| DHR | Danaher Corp | 38.55 | -123.96% |
| IDXX | Idexx Laboratories Inc | 40.58 | -125.22% |
| ILMN | Illumina Inc | 44.12 | -127.42% |
| RVTY | Revvity Inc | 52.68 | -132.74% |
| VCYT | Veracyte Inc | 53.71 | -133.39% |
| ICLR | Icon Plc | 57.45 | -135.71% |
| SHC | Sotera Health Company | 74.08 | -146.05% |
| WAT | Waters Corp | 102.79 | -163.89% |